Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,742 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,122 of 1,311 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,744 total, page 8 of 35
Neuraxial Ultrasound Device Study
NCT06281249
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease
NCT07646652
Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker-Enriched Trial
NCT07337655
Empowered Relief for Caregivers
NCT07636980
Clinical Evaluation of the Origin Intubation System
NCT07189182
Smart Talk: Cannabis Awareness and Prevention Curriculum Evaluation
NCT07357454
A Phase I/II, First-In-Human Trial to Evaluate the Safety, Tolerability, and Pharmacokinetic Activity to Prevent or Treat Neuropsychiatric Symptoms in Pediatric Subjects With Timothy Syndrome
NCT07600658
Smartshoes for Freezing of Gait in Parkinson's Disease
NCT07001072
Planetary Health and Environmental Justice in Construction Career Education
NCT07315919
Outcomes Registry After Ketamine Infusions for Chronic Pain: A Longitudinal Evaluation
NCT07648771
Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
NCT07634536
Cilostazol for Prevention of Recurrent Stroke Trial
NCT07174414
Advancing Scalable Alcohol Brief Interventions in the ED: A Trial of Conversational AI With Digital Reinforcements
NCT07661563
TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation
NCT07634562
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
NCT07594431
Palatable Elemental Diet for Gastrointestinal Symptoms in Chronic Pancreatitis
NCT07559448
Engaging Family Members During Early SUD Treatment: A Hybrid Trial
NCT07579299
Overvaluation of Weight and Shape Intervention vs The Body Project
NCT07678554
Finger Plethysmography to Predict Fluid Responsiveness in Healthy Pregnancy and Severe Preeclampsia
NCT07430254
Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
NCT07403981
Adapting the Stanford Obstetric Recovery Checklist in Postpartum Women to a Digital Health Platform: A Feasibility Study
NCT07408557
Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)
NCT07601295
A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement
NCT07615270
COMUNICAR: Community-Led Family-Centered Communication for Cancer Survivorship Care
NCT07606443
Study of Psilocybin Under Anesthesia Controlled by EEG
NCT07479550
A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients
NCT07676136
Perioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation
NCT07537894
Ultrasonic Debris Clearance to Promote Brain Resilience
NCT07573982
The Role of Amnion Membrane Allografts in Nipple Preservation
NCT06073808
Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression
NCT07528157
Reducing Adult Inpatients Anxiety With Virtual Reality Meditation
NCT06234254
Light and Sleep Fragmentation
NCT06009289
Healing Hearts of Hospitalized Patients
NCT06935604
Sensory Substitution and Brain Plasticity Following Vision Loss
NCT07450677
Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging
NCT04662554
Laboratory Heat Biomarker and Cooling Interventions
NCT07617649
Topical Insulin for Glaucoma (TING2)
NCT07619482
Standardized Adaptive Music Medicine for Suicidality
NCT07610785
Animated Storytelling to Promote Colorectal Cancer Screening
NCT07522177
Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease
NCT07215481
89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC
NCT05423197
Ultrasound for Peripheral Nerve Modulation
NCT07572591
Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension
NCT07605468
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
NCT07302776
Use of Augmented Reality and Virtual Reality During Cognitive Behavioral Therapy for Needle Phobia
NCT07042074
A Novel Auditory Application for Distraction in Pediatric Patients
NCT06922032
Technology-Based Distractions for Minor Procedures
NCT06924814
Outcomes of CTAK Surgery
NCT07474870
Evaluating a Digital Intervention to Improve Resilience and Reduce Stress in Stanford Populations
NCT07565571
Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
NCT07355894
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Stanford University: open-pipeline peers nationwide
Peers matched on 1,744 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Stanford University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,744 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- University of California, San Francisco · 1,713 trials · 16% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Baylor College of Medicine · 15% recruiting · 616 trials
- Wake Forest University Health Sciences · 15% recruiting · 1,140 trials
Related
What to do with this Stanford University page
1,744 registered trials is a research-attention snapshot, not an endorsement of Stanford University or any single study.
- 264 of Stanford University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Autism Spectrum Disorder is the condition Stanford University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autism Spectrum Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Stanford University pipeline card: 1,744 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.